טוען...
Liquid Biopsy in Pediatric Renal Cancer: Stage I and Stage IV Cases Compared
Pediatric renal cancer is rare, and robust evidence for treatment recommendations is lacking. In the perspective of personalized medicine, clinicians need new biomarkers to improve risk stratification and patients’ follow-up. Herein, we analyzed some liquid biopsy tools, which have been never tested...
שמור ב:
| הוצא לאור ב: | Diagnostics (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7599903/ https://ncbi.nlm.nih.gov/pubmed/33053902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10100810 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|